Literature DB >> 30950666

Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC).

Aaron C Tan1, Yi Lin Teh1, Gillianne G Y Lai1, Daniel S W Tan1.   

Abstract

Entities:  

Keywords:  EGFR mutation; nizartinib; non-small cell lung cancer; osimertinib; third generation EGFR TKI

Year:  2019        PMID： 30950666     DOI： 10.1080/14737140.2019.1604228

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  4 in total

1.  Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.

Authors:  Weian Song; Shouyin Di; Junqiang Liu; Boshi Fan; Jiahua Zhao; Shaohua Zhou; Siyu Chen; Hai Dong; Caiying Yue; Taiqian Gong
Journal:  Thorac Cancer       Date:  2020-02-28       Impact factor: 3.500

2.  Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies.

Authors:  Seong Bok Jang; Kyeong Bae Kim; Sujin Sim; Byoung Chul Cho; Myung-Ju Ahn; Ji-Youn Han; Sang-We Kim; Ki Hyeong Lee; Eun Kyung Cho; Nahor Haddish-Berhane; Jaydeep Mehta; Se-Woong Oh
Journal:  JTO Clin Res Rep       Date:  2021-09-08

3.  Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.

Authors:  Meredith S Eno; Jason D Brubaker; John E Campbell; Chris De Savi; Timothy J Guzi; Brett D Williams; Douglas Wilson; Kevin Wilson; Natasja Brooijmans; Joseph Kim; Ayşegül Özen; Emanuele Perola; John Hsieh; Victoria Brown; Kristina Fetalvero; Andrew Garner; Zhuo Zhang; Faith Stevison; Rich Woessner; Jatinder Singh; Yoav Timsit; Caitlin Kinkema; Clare Medendorp; Christopher Lee; Faris Albayya; Alena Zalutskaya; Stefanie Schalm; Thomas A Dineen
Journal:  J Med Chem       Date:  2022-07-15       Impact factor: 8.039

4.  Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).

Authors:  Urška Janžič; Nina Turnšek; Mircea Dediu; Ivan Shterev Donev; Roxana Lupu; Gabriela Teodorescu; Tudor E Ciuleanu; Adam Pluzanski
Journal:  Curr Oncol       Date:  2022-08-17       Impact factor: 3.109
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.